<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02606825</url>
  </required_header>
  <id_info>
    <org_study_id>VILMA</org_study_id>
    <nct_id>NCT02606825</nct_id>
  </id_info>
  <brief_title>VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years</brief_title>
  <official_title>VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years or Not Candidates for Intensive Chemotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PETHEMA Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PETHEMA Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective study to analyze the therapeutic results and clinical evolution all
      patients diagnosed with AML and aged ≥ 60años or not candidates for chemotherapy intensive,
      treated according to the different schemes available, including supportive care or
      palliative.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately in 6 months, collect and review the retrospective data.

      During this period, and in order to ensure an excellent quality of the collected data,
      perform constant monitoring and real-time data received in 2 phases:

        1. Monitoring &quot;in situ&quot; in the focal point: once the information is received before shall
           enter in the database, will be reviewed each case report data (CRD) for screening for
           inconsistencies and issue unresolved issues (queries) to sender data center. After
           entering the information in the database is carry out and resolve those queries that
           have arisen after consultation Data tables in order to locate inconsistencies or
           unavailable fields.

        2. Telephone Monitoring: data shall be verified through telephone consultations all centers
           to verify and update recruitment and monitoring patients . To ensure the completion,
           accuracy and data quality is monitored by telephone at least 30% of registered patients.

             -  Final statistical analysis (approximately 8 months from baseline).

             -  Publication of results.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Response Rate</measure>
    <time_frame>8 months</time_frame>
    <description>The main objective of this study is to retrospectively evaluate the therapeutic results in the LMA in all patients older than 60 years or not candidates for intensive chemotherapy in different stages of the disease, regardless of the treatment received, and even if they do not have received (support or palliative treatment, exclusively</description>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>AML</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Registry of AML patients &gt; 60 years</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients aged ≥60 years, diagnosed of AML or not candidates to intensive chemotherapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged ≥60 years, diagnosed of AML or not candidates to intensive chemotherapy

        Exclusion Criteria:

          -  No exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pau Montesinos, Dr</last_name>
    <email>montesinos_pau@gva.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital La Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pau Montesinos, Dr</last_name>
      <email>montesinos_pau@gva.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2015</study_first_submitted>
  <study_first_submitted_qc>November 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2015</study_first_posted>
  <last_update_submitted>January 9, 2018</last_update_submitted>
  <last_update_submitted_qc>January 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

